Skip to main content
PLOS One logoLink to PLOS One
. 2021 Nov 18;16(11):e0260168. doi: 10.1371/journal.pone.0260168

Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis—A multi-methods analysis of data from a multicentre survey

Matthew Gaskins 1,*, Mary Katherine Sammons 1, Frank Kutscha 1, Alexander Nast 1, Ricardo Niklas Werner 1
Editor: Peter A Newman2
PMCID: PMC8601504  PMID: 34793575

Abstract

Background

While our knowledge of what motivates men who have sex with men (MSM) to use HIV pre-exposure prophylaxis (PrEP) has grown in recent years, quantitative survey-based studies have not asked MSM explicitly to name their motivations. We did so using a qualitative open-ended question and aimed to categorise the responses and explore whether these were related to where MSM were located along a conceptual continuum of PrEP care.

Methods

In a multicentre survey examining knowledge and use of PrEP among MSM in Berlin, Germany, we additionally asked an open-ended question about motivations for using or considering PrEP. Data were collected from 10/2017-04/2018. One researcher developed a thematic framework deductively from the literature and another did so inductively from the free-text data, and a merged framework was used to code responses independently. We used Fisher’s exact test to assess whether the frequency of motivations differed significantly between respondents using or considering PrEP.

Results

Of 875 questionnaires, 473 were returned and 228 contained a free-text response. Motivations in the following categories were reported: (1) Safety/protection against HIV (80.2% of participants, including general safety; additional protection to condoms), (2) Mental well-being and quality of life (23.5%, including reduced anxiety; better quality of life), (3) Condom attitudes (18.9% intent not to use condoms), (4) Expectations about sexuality (14.4%, including worry-free sex or more pleasurable sex, with explicit mention of sex or sexuality), (5) Norms/social perspectives (0.8%). The difference in frequencies of motivations between those using or considering PrEP was not statistically significant.

Conclusions

Safety and protection against HIV, particularly having additional protection if condoms fail, were the most common motivations for using or considering PrEP, followed by mental well-being and quality of life. Many respondents reported several motivations, and responses overall were heterogeneous. This suggests that approaches to increase PrEP uptake that focus exclusively on its effectiveness in preventing HIV are unlikely to be as successful as a holistic approach that emphasises multiple motivations and how these fit into the broader sexual and psychological health of MSM.

Introduction

Men who have sex with men (MSM) continue to be the population most affected by HIV in the United States (US) and Europe, comprising 69% of new HIV diagnoses in the US [1] and 52% of new diagnoses (where the route of transmission was known) in the European Union (EU)/European Economic Area in 2018 [2]. An important and still relatively new tool to prevent HIV is pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate, which was approved for once-daily use in at-risk populations in the US in 2012 and in the EU in 2016. However, despite evidence of its high efficacy and safety [317], uptake among those at high risk of HIV acquisition has been slow. As of late 2019, approximately 224,000 people in the US were estimated to have received a prescription for PrEP, representing only a small proportion of the 1.1 million individuals estimated by researchers at the US Centers for Disease Control and Prevention (CDC) to have indications for it based on data from 2015 [1820]. This is unfortunate given that the substantial declines in HIV incidence among MSM in London [21], San Francisco [22] and New South Wales, Australia [23], observed in the past several years are thought to be due, at least in part, to PrEP alongside other crucial prevention strategies such as treatment as prevention (TasP) and the continued promotion of condom use. In Berlin, the decline in HIV incidence among MSM has been smaller [24], and affordable PrEP has been accessible through formal channels in Germany only since autumn 2017.

In Europe, where health policy makers and payers in many countries are still debating whether and how best to integrate PrEP into their publicly funded health systems and broader HIV prevention strategies [2528], data on PrEP uptake are sparse. The most recent and comprehensive figures are from a 2019 study using data from the European MSM Internet Survey (EMIS-2017) to estimate the gap between self-reported PrEP use and expressed need for PrEP in the EU. Using this definition, the authors found that an estimated 17.4% of MSM, or 500,000 individuals, in the EU who were very likely to use PrEP were not able to access it [29]. At 12.6%, the PrEP gap for Germany in 2019 was smaller than the EU average [29], but not inconsiderable, and was similar to a finding of the first facility-based paper survey of PrEP use among MSM (N = 470) in Berlin in 2017/18, of which the current study is a part: in the survey, 12.9% of participants who reported never having used PrEP (who comprised 82.3% of the sample) strongly agreed with the statement that they would like to do so [30]. The most frequently reported barriers to PrEP use by these participants were worries about adverse effects, cost, not having a doctor who prescribes it, and, despite a high awareness of PrEP, a lack of information on its pros, cons and proper use [30].

To improve the implementation of PrEP, a range of authors over the past decade have proposed and refined several models of a continuum or “cascade” of PrEP care [3137]. Most of the earlier models are largely based on a biomedical approach that assumes HIV prevention is the main priority in a person’s sexual decision-making and therefore evaluate this decision-making chiefly in terms of risk [38] and in a linear fashion. For example, the model proposed by Nunn et al. (2017) comprises nine steps ranging from identifying individuals at the highest risk of HIV to an end goal of retaining individuals in PrEP care [33]. In contrast, one of the more recent iterations of the PrEP care continuum, developed by Newman et al. (2018), follows a more holistic notion of personhood rooted in the results of their own qualitative analysis and the extensive anthropological and ethnographic literature on HIV prevention [37]. Their model considers the psychological, interpersonal, social and community phenomena that affect PrEP use and non-use, resulting in an augmented PrEP cascade that incorporates alternative decision-making, pathways (such as those with the end goal of intermittent use or discontinuation), and psychosocial impacts [37]. Regardless of the epistemological roots and approaches of these different models, however, what all of them share is that each stage in the proposed cascade represents a potential point of intervention to improve PrEP implementation among those for whom PrEP is a desired and viable option [32, 33]. At the same time, each of these steps is characterised by unique but overlapping sets of barriers and enablers that must be considered if we are to understand more fully how and why individuals move from one step to another–an understanding that is crucial to developing interventions to improve the implementation of PrEP, and HIV prevention strategies more generally, that are efficient, effective and, ideally, support the broader sexual and psychological health of MSM.

Since 2012, evidence on the structural, sociocultural and behavioural barriers to PrEP implementation has grown considerably. These are manifold and include cost and lack of insurance coverage (e.g., [29, 3943]), access to providers willing to prescribe PrEP (e.g., [18, 41, 44]), concerns among providers about increased sexual risk compensation (e.g., [29, 39]), but also, among those using or considering PrEP, concerns about side effects (e.g., [18, 39, 42, 43, 45]), stigma and discrimination (e.g., [18, 39, 43, 4648]), and low perceived risk of infection (e.g., [18, 4953]). Until recently, one significant gap in the literature was the lack of data on individuals’ motivations for taking PrEP. Indeed, in their comprehensive early review of research on the acceptability of PrEP and treatment as prevention (TasP), Young and McDaid (2014) identified motivations for PrEP use and adherence as one of the main areas in which further research was needed in order to identify “when, where and for whom PrEP and TasP would be most appropriate and effective” [45, p. 195].

A number of researchers, particularly in anthropological, ethnographic and other primarily qualitative lines of enquiry, have since stepped up to the plate to examine this topic. By exploring the subjective experiences of MSM in their navigation of PrEP, these authors have identified, mostly through in-depth interviews or in focus groups, numerous and varied motivations for using (or not using) PrEP that call into question the usefulness of biomedical approaches to PrEP implementation that de-emphasise psychosocial phenomena. In many cases, the motivations identified in these studies have stemmed from powerful affective experiences, such as being freed from sometimes decades-long, often cyclical anxiety about HIV infection [37, 38, 54, 55]; feeling empowered, able to make one’s own informed choices, in control or autonomous [37, 56]; and feeling less fear and shame in relation to pre-existing high-risk sexual behaviours alongside greater sexual satisfaction and intimacy [57, 58]. The qualitative literature also reports motivations related to fearing or experiencing PrEP-related stigma, such as beliefs that PrEP is only for those who are highly promiscuous [56, 59]; being labelled a “Truvada whore” (or similar) in lesbian, gay, bisexual, transgender, intersex and other gender diverse (LGBTI+) media, or by peers or even friends [60]; encountering provider-level stigma, including judgemental behaviour about the decision to use PrEP [35]; or experiencing, as a PrEP user or non-user, increased pressure to engage in condomless anal intercourse [37, 58, 61].

Among the studies that have explored motivations using survey-based quantitative methods, many have approached the subject in an indirect fashion using, for instance, correlation or regression analysis to identify factors associated with PrEP use, non-use, willingness to use PrEP or PrEP acceptability. A recent example is an analysis of data from a national, online, open-prospective observational study among MSM in Australia by Keen et al. (2020), who found that PrEP use was independently associated with lower levels of HIV anxiety among PrEP-eligible men [54]. Another example is the correlation between lower perceived HIV risk and PrEP non-use or PrEP discontinuation, which has been reported in large number of studies to date (e.g., [31, 5153, 56, 58]). Furthermore, in a cross-sectional study of 164 HIV-negative MSM in HIV seroconcordant negative primary partnerships who were not taking PrEP, Gamarel et al. (2015) found that age, education and intimacy motivations for condomless sex were associated with PrEP adoption intensions in a multivariate model based on data elicited using interview-administered survey questions and assessment scales. Clearly, all of these factors can be interpreted as motivations for considering or using PrEP, but in none of the examples mentioned above did the survey participants actually describe them as such. Indeed, among this latter stream of the quantitative literature, we were unable to identify any surveys that explicitly asked MSM to name or describe their motivations for taking PrEP, whether by providing them with a list of pre-specified motivations or the possibility of writing a free-text response.

While in-depth qualitative interviews and focus groups are probably the ideal way to explore the complex affective phenomena in this area of enquiry, there are several possible methodological advantages to eliciting such qualitative information using a self-administered survey tool: positioning an open-ended question amidst many closed questions might invite quick, spontaneous responses, and being open-ended it would, moreover, not be influenced by pre-specified categories or subjects (as would be the case with multiple choice items and/or the use of Likert scales) [62, 63]. Also, compared to data from a qualitative interview, the responses to such a question are more amenable to being coded and then analysed using a frequentist approach, and correlations with responses to the closed questions in the survey can be explored. The results can subsequently be reflected against those of previous, more in-depth qualitative research, with the aim of confirming, refuting, complicating or contextualising these. Moreover, whereas some previous work on different models of the PrEP care continuum has located participants of various cohorts along the respective cascade, to our knowledge no studies to date have attempted to identify whether the motivations of participants at one location in a PrEP care continuum might differ significantly from those at another location in the continuum. Lastly, it should also be noted that the focus of much of the qualitative and quantitative research on PrEP motivations to date has been on the US context, as well as on Australia, Canada and the United Kingdom. Perhaps not surprisingly given the four-year lag in the approval of PrEP in the EU/EEA [64], data from this region are minimal in comparison, and Germany is no exception in this regard.

To help fill this gap in the literature, we conducted a multicentre, paper-based survey in late 2017/early 2018 of almost 500 MSM in Berlin with a self-reported negative or unknown HIV serostatus. In it, we explored participants’ knowledge and use of HIV pre-exposure prophylaxis using mostly closed questions. The results of this part of the survey are reported elsewhere [30]. The survey also had an open-ended question in which we explicitly asked participants who were using or considering PrEP to write what their main motivation was for doing so. In the current paper, we present the results of a multi-methods analysis of participants’ free-text responses to this question. Our primary aim was to identify, describe and categorise the motivations of MSM in Berlin to use or consider using PrEP. Additionally, drawing upon results from the quantitative part of the survey, we sought to explore whether motivations differed between participants who had already started taking PrEP and those who were still considering it. Such information could help clinicians, sexual health counsellors and policy makers develop and distribute targeted information and advice to individuals at several steps of the PrEP care continuum and thereby improve the implementation of PrEP in Germany and beyond.

Materials and methods

Study design, ethics approval and informed consent

We used an anonymous, self-administered, paper-based questionnaire, available in German and English, to conduct a multicentre, cross-sectional survey of MSM in Berlin. The local institutional ethics committee at Charité–Universitätsmedizin Berlin approved the study protocol, the format and content of the questionnaire, and the information cover sheet for participants (EA1/162/17; 28/09/2017). All participants gave informed verbal consent to their physician or sexual health counsellor in English or in German before filling in the questionnaire. Participation was voluntary, and neither the centres nor the participants received any incentives to take part. The survey period was from 1 October 2017 to 2 April 2018. The questionnaires and information cover sheet can be accessed in full, in both English and German, in the publication of the quantitative study results by Werner et al. (2018) [30].

Sampling methods, participants and settings

To be eligible, participants had to identify as male, be aged 18 years or older, report having sex with men, and have a self-reported negative or unknown HIV status. We collected data from a range of settings, namely all four non-municipal counselling and testing centres for the sexual health of LGBTI+ people, as well as six large HIV specialist practices in Berlin. The former are non-commercial walk-in centres funded by the state government of Berlin and through private donations. They offer a range of low-barrier services, including community outreach and anonymous counselling on legal, immigration and health issues for LGBTI+ adults and adolescents, as well as affordable testing for STIs, including HIV. They are not permitted by law to prescribe medication. All clients attending the walk-in centres for STI screening or counselling were offered participation in the study by the centre staff.

HIV specialist practices in Germany offer a full range of generalist and sexual health services to LGBTI+ people regardless of whether they are living with HIV, and indeed can serve as the designated GP/family doctors for these individuals. The practices are owned and staffed by physicians, and consultations usually require an appointment, but walk-ins are possible. In total, 11 such practices from seven districts in Berlin were invited to participate in the study. We chose these purposively based on their geographic spread across Berlin and our awareness that they had been willing to take part in previous research projects related to HIV and other STIs. In these practices, we asked doctors to include every eligible patient, irrespective of the reason for the consultation, in a consecutive manner.

During the data collection period (1 October 2017 to 2 April 2018), PrEP was available in Germany only by means of a private prescription, which could be written by any licensed doctor. About half way through this period, the price of a month’s supply of generic PrEP in Germany fell from approximately 600 euros to as low as 50 euros [30]. The relevant guideline for identifying at-risk patients and prescribing PrEP is the German and Austrian Guideline on HIV pre-exposure prophylaxis [65], but its recommendations are not binding. The German system of statutory health insurance began to cover the costs associated with PrEP in September 2019.

All of the HIV and STI testing and counselling centres in Berlin (n = 4) participated in the study, as did six of the 11 HIV specialist practices we had invited. Of the 875 questionnaires distributed by the participating centres, 473 were returned (response rate 54.1%). Three participants were excluded because they reported in the questionnaire that they were living with HIV. Of the remaining 470 questionnaires, 259 contained a free-text response to the question about participants’ main motivation for using PrEP or considering its use. Thirty one of these responses were considered invalid because the participants had disagreed/strongly disagreed with the statement “I would like to take PrEP” (n = 30) or because they responded “no” to the question whether they had ever used PrEP but had indicated in their response to the statement “I would like to take PrEP” that it was not applicable to them because they were already taking it (n = 1). This resulted in a sample of 228 questionnaires with a valid free-text response for analysis.

Questionnaire format and content

The questionnaire was two pages in length and consisted mostly of closed, multiple-choice questions on participants’ knowledge and use of HIV pre-exposure prophylaxis, as well as demographic data and information on their sexual behaviour and HIV risk. Additionally, the survey had the following open-ended question: “If you are considering or already using PrEP, what is your main motivation for this?” The question gave space for responses of one to two sentences. A cover page gave a brief description of PrEP and explained the purpose of the survey.

Qualitative data analysis

We defined our units of analysis as the individual motivations for using or considering PrEP rather than the free-text response as a whole. We applied a framework analysis approach to code each motivation, using high-level themes to categorise the data [66]. To help ensure that the analysis was not driven primarily by our theoretical interests and analytic preconceptions, we took a combined deductive and inductive approach to developing the coding framework [66, 67]: One researcher (RNW) created a set of categories and subcategories deductively based on the findings of a structured search of the literature for existing frameworks and models for characterising motivations for PrEP use, whereas a second researcher (MS) created a separate set of categories and subcategories inductively based on a pilot coding and analysis of a randomly selected subset of 75 free-text responses. These two classification systems were subsequently merged by the two researchers through discussion, with discrepancies and disagreements resolved by consensus in a series of meetings facilitated by a third researcher (MG).

The first researcher (RNW), who created a set of categories and subcategories deductively, took the following approach: To identify studies or reviews reporting a classification system or listing categories of motivations to use PrEP, he searched MEDLINE on 4 April 2018 using the search terms “motivation” and “PrEP”, with time limits set to the five years before this date. Categories identified in the literature were noted without further assessment of the quality of the studies. The search yielded 61 records whose abstracts and titles were screened for eligibility, yielding six records to be evaluated in full text [51, 58, 6871]. Two of these studies were used to derive an initial categorisation system for motivations: Dubov et al. (2018) reviewed factors associated with PrEP uptake and categorised these factors along the Information-Motivation-Behavioural Skills model [51]. Their construct of motivation comprised four domains, each of which is attributed various further subdomains. Frankis et al. (2016) analysed qualitative data from in-depth interviews to deduce motivations for potential PrEP use, including situations of increased need for protection from acquiring HIV [68].

The second researcher (MS), who developed a set of categories and subcategories inductively, took the following approach: first, the third researcher (MG) familiarised himself with the entire qualitative dataset by reading and re-reading all free-text responses to make a pragmatic assessment of the number of these that would need to be coded before saturation was reached (i.e., roughly one third of all valid responses). Subsequently, a list of randomly generated numbers was appended to the qualitative dataset, and the responses numbered between one and 75 were sent to the second researcher for pilot coding. Coding was undertaken in a manner that was both open (i.e., with codes being assigned to describe as many perspectives as possible, such as particular behaviours, intentions, values, beliefs and emotions) [66] and circular (i.e. looping or cycling repeatedly between the qualitative codes assigned to the data and the data itself, and recoding, considering emergent categories, and recategorising as needed) [72].

After the two classification systems had been merged, the final categories comprised: safety/protection against HIV, expectations about sexuality, mental well-being and quality of life, condom attitudes, and norms/social perspectives. Table 1 gives an overview of the categories and subcategories in our coding system, providing definitions for each, as well as references to the pertinent literature.

Table 1. Overview of final coding framework and categorisation system with definitions (categories and subcategories listed in alphabetical order).

Category Subcategory
CONDOM ATTITUDES [51] Desire or intent to engage in condomless sex
Responses are coded in this subcategory if they refer to the desire or intent to engage in condomless sex. Negative attitudes towards condom use and reporting episodes of condomless intercourse have been described as being associated with the intention to use PrEP [73].
This category comprises two subcategories for coding responses that refer to respondents’ attitudes towards condom use.
Difficulties with condom use
Responses are coded in this subcategory if they mention difficulties with condom use as a motivation to use PrEP [55].
EXPECTATIONS ABOUT SEXUALITY Expectations of more pleasureful sex or increased intimacy and closeness (when not using a condom)
Responses are coded in this subcategory if they include the expectation of more pleasureful sex, intimacy or closeness as a motivation to use PrEP, irrespective of whether the response refers to using condoms. Believing that condoms reduce intimacy and closeness and/or sexual pleasure is a factor that has been described as associated with the intention to use PrEP [37, 55, 58].
This category comprises two subcategories for coding responses that refer to respondents’ expectations about sexuality while using PrEP.
Expectations of worry-free sex
Responses are coded in this subcategory if they refer to the expectation of worry-free or less worrisome sex as the motivation for using PrEP [37]. In contrast to the subcategory “Reducing anxiety, fear, or worries of being infected with HIV” under the category “Mental well-being and quality of life”, responses here had to mention sex or sexuality explicitly.
MENTAL WELL-BEING AND QUALITY OF LIFE Desire for a healthy life
Responses are coded in this subcategory if they refer to the general desire to increase health or longevity, or to lead a healthy life.
This category comprises four subcategories for coding responses that refer to respondents’ mental well-being or aspects of general health. Desire to increase quality of life or sexual/personal freedom
Responses are coded in this subcategory if they refer to the desire to increase quality of life, mental well-being, general health, or sexual or personal freedom as the motivation to use PrEP [37].
Reducing anxiety, fear, or worries of being infected with HIV
Responses are coded in this subcategory if they include the desire to reduce anxiety, fear or worries about being infected with HIV [37, 38, 54, 55]. Unlike the subcategory “expectations of worry-free sex”, this subcategory does not include responses that refer explicitly to the act of sex.
Reducing periods of anticipated regret
Responses are coded in this subcategory if they included the desire to decrease periods of anticipated regret or worries. The cognitive-based emotion of anticipated regret from engaging in HIV-risk behaviour has been described as an important determinant of the intention to use PrEP [51].
NORMS / SOCIAL PERSPECTIVES Perceiving condomless sex / PrEP intake as a social norm
Responses are coded in this subcategory if the answer refers to perceptions of PrEP use as a social norm or the need to use PrEP as the only means of personal protection in a social environment that insists on condomless sex [37, 58, 61].
This category comprises two subcategories for coding responses that refer either to perceptions of PrEP use as a social norm or that reflect upon PrEP use in terms of social or public health perspectives.
Prevention altruism [51]
Responses are coded in this subcategory if the respondent refers to a general public health perspective of reducing the burden of HIV epidemics. General public health concerns have been described as a facilitator of engaging in safer sex practices [74].
SAFETY/PROTECTION AGAINST HIV Additional protection against HIV
Responses are coded in this subcategory if they reflect the respondent’s wish to have additional protection against HIV, or additional safety or security, by using PrEP as a “backup preventive strategy”. This has been described in the literature as a specific motivation to use PrEP [68]. Safer sex intentions have been shown to be linked with the motivation to use PrEP [73].
This category comprises eight subcategories for coding responses that refer to protection against HIV or general safety considerations, as well as more specific aspects of protection or safety for oneself or for others.
Autonomy and self-empowerment in the protection against HIV
Responses are coded in this subcategory if they reflect the respondent’s wish to protect himself from being infected with HIV using a method of protection that lies within his own responsibility and is not dependent on his partners’ reliability or will to use condoms [37, 56].
Being at self-perceived risk of HIV
Responses are coded in this subcategory if they reflect the respondent’s general perception of being at risk of acquiring HIV due to specific circumstances, such as having sex with many casual partners or being in a relationship with a person living with HIV. Self-perceived risk of acquiring HIV has been described as a factor that may motivate individuals to seek preventive services. Considering oneself as being at risk of HIV infection has been shown to be correlated with self-perceived eligibility for PrEP use [31, 5153, 56, 58].
PrEP as an affordable way to protect against HIV
Responses are coded in this subcategory if they mention the affordability or cost of PrEP as an option to protect oneself from being infected with HIV.
Protecting partner(s) or relationship(s) from HIV infection
Responses are coded in this subcategory if they reflect the respondent’s wish to protect his (sex) partners’ health or well-being or if the answers included relationship-associated aspects. Attitudes towards using PrEP have been shown to be linked with considerations of protecting primary and/or outside partners [55, 73]. Concerns for the sexual partners’ risk of acquiring HIV and general public health concerns have also been described as a facilitator of engaging in safer sex practices [74].
Protection against HIV during periods of anticipated increased risk (e.g., recreational drug use, holidays)
Responses are coded in this subcategory if they reflect the respondent’s wish to protect himself from being infected with HIV during specifically defined events (e.g., recreational drug use) or periods (e.g., holidays) that are accompanied by an anticipated increased risk of being infected with HIV. PrEP has been described as an option for situations in which regular patterns of sexual practice might be disrupted, such as holidays or in the event of alcohol and/or drug use [53, 68].
Protection against HIV, prevention of HIV and general safety
Responses are coded in this subcategory if they reflect the respondent’s general wish to protect himself from being infected with HIV, or his generally expressed need for safety, without mentioning specific circumstances or specifying aims beyond (his individual) protection.
Protection against HIV when not using condoms
Responses are coded in this subcategory if they reflect the respondent’s wish to protect himself from being infected with HIV explicitly without having to use condoms.

Two researchers (RNW, MS) subsequently used this framework independently to identify, code and classify individual motivations in each free-text response (including the 75 responses used in the pilot coding). Meetings among all three researchers were held at regular intervals during the coding and classification process to discuss potential emerging new categories or subcategories during the coding. Ultimately, no substantial changes to the framework were needed during this process, although we did clarify the definition for the subcategory “Expectations of worry free-sex” to require, in contrast to the subcategory “Reducing anxiety, fear, or worries of being infected with HIV”, the explicit mention of sex or sexuality. Moreover, a subcategory “Desire to increase quality of life or sexual freedom” was broadened to include “sexual/personal freedom”. Furthermore, even though the number of responses in the category “Norms / social perspectives” was minimal, we decided to retain it because of its prominence as a finding in the qualitative literature (e.g., [37, 58, 61]) and our desire not to take an overly frequentist approach to reporting the qualitative data. Lastly, while preparing the manuscript we decided to use the term “quality of life” instead of “general health” to describe the category “Mental health and quality of life” because we felt the term better captured the nature of the responses we had assigned to various subgroups in this category.

There was a high degree of agreement between the coding results of the two researchers (Cohen’s Kappa = 0.837, 95% CI: 0.794–0.880). The third researcher (MG) reviewed all disagreements and resolved these with the other researchers through discussion.

Quantitative data analysis

No formal sample size calculations were performed for the survey. Based on feasibility considerations, we aimed at collecting data from approximately 500 participants. Data were analysed using descriptive statistics and Fisher’s exact test of independence to assess whether the frequency of motivations for PrEP, by category, differed in a statistically significant manner (alpha level 0.05) between the subset of the sample that reported using PrEP or having a history of its use and the subset that reported considering PrEP.

In our data set, we classified respondents who indicated no previous PrEP use, reported a motivation, and did not disagree or strongly disagree with the statement that they would like to use PrEP as considering PrEP use. Within all of the models of the PrEP care continuum developed to date, this group could be located at any of the steps before the step corresponding to PrEP initiation (e.g., “Initiate PrEP” in the model by Newman et al. (2018) [37], Stage 4b of “Stage 4: PrEP action and initiation” in the model by Parsons et al. (2018) [34], or “Step 7: Initiating PrEP” in the model by Nunn et al. (2017) [33]). Respondents who reported that they were currently using PrEP or had used it in the past (i.e. “Yes, but not on a regular basis”, “Yes, I regularly use it before and after risk sex (as needed)”, “Yes, I use it continuously”), reported a motivation, and did not disagree or strongly disagree with the statement that they would like to use PrEP were classified as using PrEP or having a history of its use. This group could be located, roughly, in “Stage 5: PrEP maintenance and adherence” of the model by Parsons et al. (2018) or at steps 8 (“Adhere to PrEP”) or 9 (“Retention in PrEP Care”) of the model by Nunn et al. (2017). However, because we included people with different PrEP trajectories (i.e., those who had used PrEP in the past but were not necessarily taking it at present), they would be more appropriately placed between the steps “Initiate PrEP” and “Retention”, with the possibility of being located at the stages “Seasonal or intermittent use” or “Discontinuation” on the augmented PrEP cascade of Newman et al (2018) [37].

For any post-hoc pairwise comparisons, we applied a Bonferroni-corrected alpha level of 0.05 divided by the number of compared pairs to account for multiple testing. To avoid a purely frequentist approach and preserve the richness of our qualitative data when reporting examples of motivational factors given in response to the open question, we chose to cite whenever possible five motivations that summarised the overall body of motivations in each subcategory, whether responses in this subcategory were frequent or rare. In cases where fewer or more than five motivations were sufficient or needed for this purpose, a different number of responses is cited. Statistical analyses were performed using Stata SE version 14.2.

Results

Demographic data, sexual behaviour and HIV risk of analysis sample

Among the 228 respondents who gave a valid free-text response to our question about motivation, 65 were using PrEP or had used it at some point in the past, and 163 were considering it. Their mean age was 36.4 years (SD 10.8, range 20–79). Table 2 shows these and other demographic and sexual risk behaviour data for these respondents (analysis sample), as well as separately for those who were using PrEP (or had a history of its use) and those who were considering it. Differences between these latter two subgroups were minor and similar to the roughly analogous subgroups reported in the publication on the quantitative results of the survey [30].

Table 2. Demographic data and sexual risk behaviour of participants who answered the question about their motivation for using or considering PrEP.

Analysis sample Participants using PrEP (or with history of its use) Participants considering PrEP use
N = 228 N = 65 N = 163
Age
Mean (SD) in years 36.4 (10.8) 33.9 (6.9) 37.3 (11.8)
Min-max in years 20–79 24–53 20–79
Not stated 9 5 4
Highest degree or level of school (N, %)
Primary education 0 (0.0%) 0 (0.0%) 0 (0.0%)
Secondary education up to year 10* 21 (9.2%) 3 (4.6%) 18 (11.0%)
Secondary educ. with apprenticeship 11 (4.8%) 1 (1.5%) 10 (6.1%)
Secondary education up to year 12** 41 (18.0%) 7 (10.8%) 34 (20.9%)
University degree 151 (66.2%) 50 (76.9%) 101 (62.0%)
Not stated 4 (1.8%) 4 (6.2%) 0(0.0%)
Financial situation (N, %)
Not always have enough money 19 (8.3%) 7 (10.8%) 12 (7.4%)
Enough money 104 (45.6%) 25 (38.5%) 79 (48.5%)
More than enough money 102 (44.7%) 30 (46.2%) 72 (44.2%)
Not stated 3 (1.3%) 3 (4.6%) 0 (0.0%)
Place of residence (N, %)
Berlin 213 (93.4%) 60 (92.3%) 153 (93.9%)
Other city in Germany 7 (3.1%) 1 (1.5%) 6 (3.7%)
Small town / rural area in Germany 0 (0.0%) 0 (0.0%) 0 (0.0%)
Other country 5 (2.2%) 1 (1.5%) 4 (2.5%)
Not stated 3 (1.3%) 3 (4.6%) 0 (0.0%)
Family origins (N, %)
Participant & both parents born in Germany 132 (57.9%) 29 (44.6%) 103 (63.2%)
One parent born outside Germany 17 (7.5%) 7 (10.8%) 10 (6.1%)
Both parents born outside Germany 19 (8.3%) 7 (10.8%) 12 (7.4%)
Participant born outside Germany 56 (24.6%) 19 (29.2%) 37 (22.7%)
Not stated 4 (1.8%) 3 (4.6%) 1 (0.6%)
Current HIV status (N, %)
HIV negative 198 (86.8%) 61 (93.8%) 137 (84.0%)
Not sure 24 (10.5%) 0 (0.0%) 24 (14.7%)
Not stated 6 (2.6%) 4 (6.2%) 2 (1.2%)
STI diagnosis in the past six months (N, %)
No 168 (73.7%) 37 (56.9%) 131 (80.4%)
Yes 57 (25.0%) 25 (38.5%) 32 (19.6%)
Not stated 3 (1.3%) 3 (4.6%) 0 (0.0%)
Role when having anal sex (N, %)
No anal sex 7 (3.1%) 0 (0.0%) 7 (4.3%)
Bottom only 21 (9.2%) 6 (9.2%) 15 (9.2%)
More bottom than top 60 (26.3%) 15 (23.1%) 45 (27.6%)
Top and bottom (versatile) 58 (25.4%) 19 (29.2%) 39 (23.9%)
More top than bottom 49 (21.5%) 12 (18.5%) 37 (22.7%)
Top only 30 (13.2%) 10 (15.4%) 20 (12.3%)
Not stated 3 (1.3%) 3 (4.6%) 0 (0.0%)
Number of anal sex partners in the past six months (N, %)
None 14 (6.1%) 0 (0.0%) 14 (8.6%)
1 22 (9.6%) 2 (3.1%) 20 (12.3%)
2 to 5 67 (29.4%) 12 (18.5%) 55 (33.7%)
6 to 10 44 (19.3%) 13 (20.0%) 31 (19.0%)
More than 10 76 (33.3%) 35 (53.8%) 41 (25.2%)
Not stated 5 (2.2%) 3 (4.6%) 2(1.2%)
Number of anal sex partners without using condom in the past six months (N, %)
None 62 (27.2%) 6 (9.2%) 56 (34.4%)
1 54 (23.7%) 7 (10.8%) 47 (28.8%)
2 to 5 71 (31.1%) 23 (35.4%) 48 (29.4%)
6 to 10 21 (9.2%) 11 (16.9%) 10 (6.1%)
More than 10 17 (7.5%) 15 (23.1%) 2 (1.2%)
Not stated 3 (1.3%) 3 (4.6%) 0 (0.0%)

STI, sexually transmitted infection

*or similar

**for example A levels, high school diploma, German “Abitur”.

See S1 Table for a comparison of the demographic data and sexual risk behaviour of participants in our analysis sample and respondents who indicated that they were neutral about or might be interesting in taking PrEP but did not provide a free-text answer to the question about their motivation (n = 104). The latter group was very similar to our analysis sample in terms of age, educational attainment and place of residence, but was different to it insofar as a substantially larger proportion of respondents were less financially secure, were unsure about their HIV status, had never used PrEP and reported engaging in sexual behaviour that put them at lower risk of HIV infection.

Motivations of the participants

The number of motivations cited by participants ranged from one to five (mean: 1.38, median: 1.0). More specifically, of the 228 responses to the question about participants’ motivation for using or considering PrEP, we coded 152 as describing one motivation, 66 as describing two motivations, 9 as describing three motivations, and 1 as describing five motivations. All free-text responses that contained multiple motivations reported these clearly as part of a list using the conjunctions “and” or “but”, a comma or other form of punctuation, or some combination of these.

Table 3 gives an overview of the different categories of motivations and the number of respondents who reported one or more motivations exclusively in each category (or combination of categories). Of the 228 respondents, 154 reported some form of safety and protection against HIV as either their only motivation (n = 121) or one of their motivations (n = 33) for using or considering PrEP. This was followed by 50 respondents who reported some form of mental well-being and quality of life as either their only motivation (n = 23) or one of their motivations (n = 27). A total of 43 respondents reported condom attitudes (i.e., a desire or intention to engage in condomless sex) as either their only motivation (n = 21) or one of their motivations (n = 22). Lastly, 31 respondents reported some form of expectations about sexuality as either their only (n = 14) or one of their motivations (n = 17). Only two respondents reported norms and social perspectives as their only motivation for using or considering PrEP. Among those respondents who reported two motivations in total, the only combinations of motivations that comprised at least approximately 5% of the analysis sample were in the categories safety and mental well-being (12 respondents, 5.3%) and safety and condom attitudes (10 respondents, 4.4%). The difference in the frequencies between the two subsamples was not statistically significant (Fisher’s exact test, p = 0.234). A post hoc pairwise comparison of the frequencies also revealed that none of them differed in a statistically significant manner between the groups when the alpha level was set to 0.003 (i.e., 0.05/13).

Table 3. Participants reporting one or more motivations exclusively in a category or combination of categories in the analysis sample, by subgroup (using or considering PrEP).


Category of motivation(s) for using or considering PrEP
Participants in analysis sample Participants using PrEP (or with history of its use) Participants considering PrEP use
N = 228 N = 65 N = 163
Safety 121 (53.1%) 30 (46.2%) 91 (55.8%)
Mental well-being 23 (10.1%) 7 (10.8%) 16 (9.8%)
Condom attitudes 21 (9.2%) 4 (6.2%) 17 (10.4%)
Expectations 14 (6.1%) 4 (6.2%) 10 (6.1%)
Norms 2 (0.9%) 1 (1.5%) 1 (0.6%)
TOTAL RESPONDENTS 181 46 135
Safety & mental well-being 12 (5.3%) 4 (6.2%) 8 (4.9%)
Safety & condom attitudes 10 (4.4%) 4 (6.2%) 6 (3.7%)
Safety & expectation 6 (2.6%) 5 (7.7%) 1 (0.6%)
Expectations & mental well-being 6 (2.6%) 3 (4.6%) 3 (1.8%)
Expectations & condom attitudes 4 (1.8%) 1 (1.5%) 3 (1.8%)
Mental well-being & condom attitudes 4 (1.8%) 1 (1.5%) 3 (1.8%)
TOTAL RESPONDENTS 42 18 24
Safety, mental well-being & condom attit. 4 (1.8%) 1 (1.5%) 3 (1.8%)
Safety, expectations & mental well-being 1 (0.0%) 0 (0.0%) 1 (0.6%)
TOTAL RESPONDENTS 5 1 4

Looking at the subcategories of motivations adds more granular information and complexity to this picture. In the safety category, responses citing general aspects of safety and protection against HIV predominated (mentioned by 40.4% of respondents), but were followed by more specific motivations, such as PrEP serving as additional protection above and beyond condom use (16.2%), being at risk of HIV infection (7.5%), or seeking protection against HIV when not using condoms (6.1%). Nine respondents (0.04%) mentioned safety or protection in relation to protecting others as opposed to themselves. In the condom attitudes category, 18.0% percent of respondents explicitly mentioned a desire to engage in condomless sex as a motivation for using or considering PrEP. Expectations about sexuality, as a category, included explicit mentions of anxiety- or worry-free sex (8.3%) and of more pleasurable sex (6.1%) as motivations. Lastly, the category of mental well-being and quality of life included motivations related to reducing anxiety, fear or worries of being infected with HIV (8.6%) and a desire to increase quality of life or sexual and personal freedom (8.3%). Table 4 gives examples of the motivations ordered along these categories; responses in German were translated into English for presentation in the table by one researcher (MG) and checked independently by the remaining authors, with disagreements resolved by consensus.

Table 4. Qualitative results: Survey respondents’ motivations for using or considering PrEP according to category and subcategory, their frequency, and representative examples.

CATEGORY: SAFETY/PROTECTION AGAINST HIV
Subcategory Frequency Example motivations
General safety/Protection against HIV/Prevention of HIV 92/228 (40.4%) “To protect myself from HIV”
“Reduce the chance of HIV infection”
“Safety regarding HIV infection”
“HIV prophylaxis”
“Health protection”
Additional protection against HIV 37/228 (16.2%) “Additional safety when having sex”
“Backup”
“I want extra protection in case a condom fails or if I make a bad decision.”
“To protect myself from HIV if the condom slips off or loses its protection for some other reason”
“Protection (double, with condom)”
Being at self-perceived risk of HIV 17/228 (7.5%) “HIV-infected partner who has just begun therapy”
“It has happened in the past, even though I didn’t intend to, that I had sex without a condom”
“Many casual sex partners from time to time”
“Protection, I live in a long-term relationship with an HIV positive guy”
Protection against HIV when not using condoms 14/228 (6.1%) “To feel safer in case of unprotected sex”
“Easy protection when having sex without a condom”
“Sex without a condom and hardly any risk of infection”
“Protection against HIV without a condom”
Autonomy and self-empowerment 9/228 (3.9%) “To protect myself more actively and not rely on others, for example regarding a condom”
“More autonomy as (I am) more a bottom”
“I have more safety and don’t have to depend on my partner keeping the condom on”
“Because I find it hard to trust people, so as a way to be more careful.”
“More control”
Protecting partner(s) or relationship(s) 9/228 (3.9%) “To protect health (mine, of my partner & of my sex partner)"
“To protect my opposite”
“Protection for me and others”
“Greater security in an open relationship”
“The knowledge that I can’t harm anybody with my actions”
“My partner has HIV and we’re in an open relationship”
Protection against HIV during periods of anticipated increased risk (e.g. recreational drug use, holidays) 5/228 (2.2%) “To avoid accidents when I’m in environments that may affect my decisions and behaviour. At a party or around the time I go for a party. I am afraid that alcohol consumption or simply condom break may expose me to HIV.”
“Addition protection during special occasions (e.g., holiday)”
“I have more security and don’t have to rely on (. . .) myself, even under the influence of alcohol, insisting on a condom in every situation”
“Protection against stupidity when drinking alcohol”
PrEP as an affordable protection against HIV 2/228 (0.0%) “Protection, low costs”
“It seems like an affordable option and viable way to help protect against HIV infection.”
CATEGORY: MENTAL WELL-BEING AND QUALITY OF LIFE
Subcategory Frequency Example motivations
Reducing anxiety, fear or worries of being infected with HIV 17/197 (8.6%) “Paranoia, fear of getting infected”
“Not constantly having to be afraid”
“Less anxiety before the next HIV test”
“My whole life there’s only been sex with a condom and fear of HIV”
“To free myself from fear”
“Although I’m putting myself at risk of getting an STD, I find the benefits of PrEP overwhelmingly because I no longer have to fear that I’ll get HIV”
Desire to increase quality of life or sexual / personal freedom 19/228 (8.3%) “Peace of mind”
“Convenience”
“Quality of life”
“Not always (….) having to take PEP”
“Personal freedom”
“Sexual freedom”
“A feeling of security”
“Uncomplicated sex”
“Spontaneous sex (…) also with casual partners”
“I’d like to try a few sex partners who I otherwise couldn’t (try out) without being on PrEP”
“So I can behave more like heterosexuals and not worry every time I choose not to use a condom”
Reducing periods of anticipated regret 8/228 (3.5%) “The psycho-stress after unprotected sex”
“No guilty conscience about unsafe sex”
“To not feel regret after unsafe sex”
“Less chance for my imagination to run away from me” (“weniger Kopfkino”)
“To have a better conscience after having unsafe sex”
Desire for a healthy life 7/228 (3.1%) “To protect (my) health”
“To not become ill”
“Longer life”
“Health”
“Stay healthy”
CATEGORY: CONDOM ATTITTUDES
Subcategory Frequency Example motivations
Desire or intent to engage in condomless sex 41/228 (18.0%) “I don’t like condoms”
“Anal sex without a condom”
“Unsafe sex”
“Unprotected sex”
“To have sex without condom with known sexual partners that test for other STDs regularly”
“Unprotected sex with partner”
“To have riskier sex”
Difficulties with condom use 2/228 (0.9%) “Protection from HIV because I can’t deal with condoms”
“Problem with condom when being a top”
CATEGORY: EXPECTATIONS ABOUT SEXUALITY
Subcategory Frequency Example motivations
Expectations of worry-free sex 19/228 (8.3%) “It’s a way to feel safer when having sex”
“More relaxed approach to sexuality”
“Unencumbered Sex”
“Sex without fear”
“To have riskier sex without fear”
“Carefree sex without worrying about HIV infection”
Expectations of more pleasureful sex 14/228 (6.1%) “More pleasure”
“Sex is more intense”
“To enjoy sex”
“To (…) enjoy sex more”
“Intense feeling during sex”
“More sensuality, more pleasure”
CATEGORY: NORMS / SOCIAL PERSPECTIVES
Subcategory Frequency Example motivations
Perceiving condomless sex/PrEP intake as a social norm 1/228 (0.4%) “More and more guys are doing bareback sex only”
Desire to eradicate HIV 1/228 (0.4%) “Eradicating HIV”

Discussion

Our study is the first multicentre, paper-based survey to ask MSM in Berlin explicitly to name their motivations for using or considering HIV PrEP. By a large margin, most respondents who answered the question cited some form of safety and protection against HIV as their only motivation or one of their motivations in this regard. Most frequently in this category, respondents mentioned being motivated by the idea of having additional protection in case of condom failure (e.g., “To protect myself from HIV if the condom slips off or loses its protection for some other reason”, “Additional safety when having sex”). Even though some 18% of respondents in our analysis sample explicitly mentioned a desire or intent to engage in condomless sex as a motivation for using or considering PrEP, these findings about safety and protection should reassure payers and practitioners who might be focusing disproportionately on the subject of sexual risk compensation, i.e., an increase in sexual behaviours that could put those who engage in them at a higher risk of infection with HIV and other STIs [7580]. Indeed, the second most frequently cited category of motivations among our respondents after that of safety and protection was that of mental well-being and quality of life. Given the alarming frequency of suicide, depression and self-harm among sexual minorities, for which there is an abundance of evidence worldwide (e.g., [8183]), our results suggest that it might be wise to attach greater weight to these beneficial effects of PrEP when deciding on its appropriateness for a given patient–and perhaps somewhat less weight than hitherto to the understandable but still largely theoretical concern of increased sexual risk compensation and STI incidence, for which the evidence is mixed [8486].

This latter finding resonates with the results of qualitative studies that have engaged with this area of enquiry, challenging the predominant biomedical approach to PrEP implementation. With regard to motivations such as those to reduce HIV anxiety, improve self-efficacy, be able to make one’s own informed choices, and feel less fear and shame, for example, our respondents wrote short but powerful responses about “not constantly having to be afraid,” living a “whole life” in which “there’s only been sex with a condom and fear of HIV”, wanting to “try a few sex partners who I otherwise couldn’t without being on PrEP”, and no longer having to “feel regret” or have “psycho-stress” after having “unprotected” or “unsafe” sex. Examining such phenomena, and affective experiences more generally, is crucial because these have been shown to have a profound impact on the sexual and psychological well-being of MSM (e.g., [35, 37, 38, 57, 59, 60]). Moreover, these motivations are also tied to ongoing decision-making about PrEP that is based on sexual risk and relationship trajectories that have been shown to be varied and dynamic [37].

This idea of moving beyond a circumscribed biomedical approach to PrEP implementation is supported by a further, and somewhat unexpected, result from our study: Even though our survey item asked only for respondents’ main motivation for using or considering PrEP, one third (76/228) of our respondents nevertheless reported more than one motivation. Although these multiple motivations often fell into the same category (most frequently into that of safety and protection), it is important to bear in mind that even in a category as seemingly one-dimensional as “safety and protection”, a broad range of subcategories could be identified, including protection during periods of anticipated increased risk, self-perceptions of being at high risk, and additional protection against HIV while using a condom. Moreover, some 20% (47/228) of respondents reported motivations in more than one category. Altogether, this suggests that approaches to PrEP counselling that seeks, where appropriate, to increase the uptake of PrEP by focusing exclusively on its effectiveness in preventing HIV is unlikely to be as successful as a holistic approach that focuses simultaneously on multiple motivating factors, particularly those related to mental health and quality of life. While this may be something that any good doctor, sexual health counsellor or social worker would do, the results of our study might nevertheless be useful as a reminder of the breadth of motivations that can influence the decision to use PrEP and encourage practitioners to seek to identify multiple (and, indeed, even apparently contradictory) factors in individual patients. This may also aid decisions to inform patients about other preventive strategies, and to provide support with broader sexual and psychological health issues, as part of a more holistic approach.

The idea of taking a more holistic approach to PrEP implementation has been the focus of several recent publications. Lacombe-Duncan et al. (2021) drew on qualitative data from in-depth, semi-structured interviews with 29 MSM recruited purposively in 2015/16 in a community setting in Toronto, Canada, to identify and explore gaps in PrEP implementation that might be amenable to social work intervention [61]. Among other results, they found that MSMs’ navigation of sexual health and risk practices was made complex by a range of sometimes contradictory factors encompassing the individual, interpersonal, organisational and structural levels. This aligns very much with the breadth of motivations reported in our survey, as well as the reporting of multiple motivations by individual respondents. Lacombe-Duncan et al. (2021) make clear that addressing such factors and, more specifically, the social determinants of health and psychosocial issues that affect PrEP engagement solely in terms of HIV infection risk and a binary decision about PrEP uptake would be wholly inadequate to support individuals with informed decision making [61]. A recently published systematic review by Pinto et al. (2018) corroborates these and, in part, our findings, and identifies the need for a range of multilevel interventions targeting multiple socioecological domains, such as interventions to help people navigate health care systems and improve referrals to mental health and supportive services, as well as provider-level interventions such as increased training and education about PrEP [43]. In their scoping review of PrEP service delivery and programming, Hillis et al. (2020) also identify a range of potentially useful multidisciplinary and innovative PrEP care pathways; however, they make the important additional point that PrEP provision in a health system actually creates new opportunities for MSM to access health services to which they might not otherwise have availed themselves, such as sexual health care, testing, treatment, counselling and STI testing and psychological support [87].

A further aim of our study was to determine whether motivations differed between individuals at two different locations on a conceptual continuum of PrEP care: those who were using it or had used it at some point in the past and those who were contemplating or considering its use. Contrary to our expectations, we were unable to identify statistically significant differences in motivations between the groups that might inform targeted approaches to increase uptake or improve adherence. From a qualitative research perspective, however, it is of value to point out that some of the differences appeared substantial and would be worthy of further investigation, ideally applying methods and a study design that would allow for quantitative hypothesis testing as well as in-depth qualitative questioning of findings. In particular, it appears that participants considering PrEP may have been more likely to cite safety as their only motivation whereas motivations in combination with the category of safety played a greater role among those using PrEP or with a history of its use. While this may be due to social desirability bias in survey research, it is conceivable that once individuals have initiated PrEP, other categories of benefits–for example related to expectations around sexuality or mental well-being–may become more readily apparent to them. Interestingly, the comprehensive review of the literature undertaken by Young et al. (2013) before the wide rollout of PrEP found that willingness to take PrEP (the closest construct to motivations that they examined) was associated with younger age, unprotected anal intercourse with casual partners and increased risk perceptions; on the other side, anxieties around medical side effects of PrEP were commonly reported in the included studies as barriers. Psychosocial correlates of willingness, such as reduced anxiety about HIV infection or an increase in self-efficacy, do not appear to have been reported as frequently in this pre-rollout phase, however. While this may simply be an artefact of the biomedical approach to these questions taken by many of the studies included in their review, it might also support the hypothesis that these positive aspects of PrEP only become more readily apparent after PrEP use has been initiated.

Some of our findings were surprising. Attitudes towards using PrEP have been shown in the literature to be linked to considerations of protecting primary and/or outside partners [73], and concerns for sexual partners’ risk of acquiring HIV and the public health have also been described as a facilitator of engaging in safer sex practices [74]. In our study, however, among the high number of respondents who reported some form of safety or protection against HIV as their only motivation or as one of their motivations (n = 154), only a few (n = 9) cited protecting their partners or relationships as a relevant motivational factor. One reason for this may be that a requirement for initiating PrEP, unlike using a condom, is that an individual gets tested for HIV. Knowing with greater certainty that they were not infected with HIV may have led them to focus more on the protective effects of PrEP for themselves rather than the thought of preventing onward transmission. Regardless, given the evidence that individuals are more averse to risk when their decisions affect others [74, 88, 89], focusing on risks to others to convince people to engage in beneficial public health behaviours remains an important part of public health messaging and initiatives. Moreover, the literature [37, 80, 90, 91] and anecdotal reports from the centres that took part in our study suggest that, increasingly, PrEP use is becoming a social norm and many individuals feel pressured to use PrEP in a social environment that insists on sex without condoms. Surprisingly, however, only one participant in our study mentioned this as a motivation for using or considering PrEP (“More and more guys are doing bareback sex only”). The reasons for this result are unclear, but may be related to an already long established culture of unprotected sex in subgroups of the gay population in large cities like Berlin, or to the fact that, at the time of our survey, PrEP had only just become available through formal channels in Germany. Regardless, the topic warrants further research, particularly of a qualitative nature.

An important strength of our survey is that we asked participants explicitly about their motivation for considering or using PrEP rather than interpreting various factors correlated with PrEP contemplation or PrEP use as motivations. Another strength is its facility-based, multicentre design and paper format, which may have avoided or ameliorated some of the disadvantages of online surveys, such as self-selection bias and multiple responses from the same individuals. Nevertheless, our study also has a number of substantial limitations beyond its cross-sectional, observational design and the obvious caveats that this entails. First, the results of survey-based studies are subject to social desirability bias [9296]. It is probable that some of our respondents indicated that their motivation for taking PrEP was safety because they wanted to project a favourable image of themselves or, despite the anonymous nature of the survey, they thought doing so would ensure continued good care from their physician or make it more likely they would obtain a prescription for PrEP. However, we found no statistically significant differences between the motivations reported by respondents who had a history of PrEP use and those who were considering it. Presumably individuals who had already taken PrEP before will have had fewer concerns about gaining access to the medication. Moreover, if reporting socially desirable motivations had been a strong force behind respondents’ answers, one might have expected, from both subgroups, a larger number of responses focusing on the protection of others or the public health more generally. Second, although our coding framework was developed and implemented in a systematic manner by three independent researchers, any set of codes and categories will always, to a certain extent, be arbitrary. We attempted to address this point by testing the assumption of independence of observations in larger and broader categories (as opposed to our subcategories), but it is possible that a different system of coding would yield different results. Third, due to our study being based on a paper survey with limited space for a free-text response, we were unable to pursue an important avenue of qualitative enquiry, namely in-depth follow-up questions leading from the general to the specific. Without this, it is impossible to know what the more superficial but also the deeper motivations for using or considering PrEP might be. In-depth interviews exploring our findings in future projects might bring more clarity. Fourth, respondents to our survey who indicated that they were neutral about or might be interested in taking PrEP but did not respond to our open question may have had different motivations than those who did provide a response. Our informal comparison of these two groups (see S1 Table) suggests that these individuals may have been less interested in PrEP because their self-perceived risk of HIV infection was lower due to their sexual risk behaviour (e.g., fewer anal sex partners and more condom use). Moreover, the findings of our study and the larger quantitative survey of which it is a part [30] are specific to MSM in Berlin and therefore limited in their generalisability. Nevertheless, they can provide a helpful comparison to the situation in cities with roughly similar populations of MSM such as London, San Francisco, Paris or New York, where the implementation of PrEP is already well underway. Fifth, because of space limitations in our paper-based survey we did not ask for explicit motivations for not using PrEP. Doing so would have added an interesting dimension to the study and allowed us to explore additional steps along the PrEP care continuum and approaches to promoting alternative prevention strategies. Sixth, although we did not exclude transgender MSM from taking part in our survey, we did not explicitly instruct participating centres to include or exclude this group. Anyone who identified as male (cis or trans) and reported having sex with other MSM could take part. Other sampling strategies could have been used to obtain meaningful data on transgender MSM’s motivations for using or considering PrEP but would have gone beyond the scope of our study.

Conclusion

As part of a broader multicentre survey of MSM in Berlin, Germany, we additionally asked participants in an open-ended question about their main motivation for using or considering the use of PrEP. While the focus of their responses lay on safety, the range of motivations was broad and could be grouped into five main categories, listed in descending order of frequency: safety and protection again HIV, mental well-being and quality of life, a desire or an intention to engage in sex without a condom, expectations about sexuality, and norms and social perspectives. There were no statistically significant differences in motivations between participants who were using PrEP already versus those who were considering its use. Many respondents reported several motivations, and responses overall were heterogeneous. This suggests that health professionals seeking, where appropriate, to increase PrEP uptake by focusing exclusively on its effectiveness in preventing HIV is unlikely to be as successful as a holistic approach that focuses on multiple motivating factors, particularly those related to mental health and quality of life. These results may inform health providers’ approach to PrEP education and prescribing, as well as the design of information campaigns and other interventions to increase PrEP uptake alongside other strategies of HIV prevention and support for the broader sexual and psychological health of MSM.

Supporting information

S1 Table. Demographic data and sexual risk behaviour of participants in analysis sample and participants who were neutral about or potentially interested in taking PrEP but who did not answer the question about their main motivation.

(DOCX)

S1 Dataset. Minimal underlying data set and codebook.

Age of respondents has been removed to ensure patient anonymity.

(XLSX)

Acknowledgments

The authors would like to acknowledge and thank the following centres and organisations Gemeinschaftspraxis Dietmar Schranz und Klaus Fischer and staff; Praxiszentrum Kaiserdamm and staff; Praxis Wünsche and staff; Novopraxis Berlin GbR and staff; Praxis Jessen2 + Kollegen and staff; Ärztezentrum Nollendorfplatz and staff; Mann-O-Meter e.V. and staff; Pluspunkt Berlin (Schwulenberatung Berlin gGmbH) and staff; Fixpunkt e.V. and staff; Berliner AIDS-Hilfe e.V. and staff for their participation in distributing questionnaires and collecting data. The study would not have been possible without the participants who consented to be part of the study. We acknowledge open access publishing support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité - Universitätsmedizin Berlin.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Centers for Disease Control and Prevention DoHAP, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. HIV by Group: HIV and Gay and Bisexual Men 2020 [Available from: https://www.cdc.gov/hiv/group/msm/index.html.
  • 2.Europe ECfDPaCWROf. HIV/AIDS surveillance in Europe 2019–2018 data. Stockholm: ECDC; 2019. [Google Scholar]
  • 3.Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine. 2010;363(27):2587–99. doi: 10.1056/NEJMoa1011205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hosek S, Siberry G, Bell M, Lally M, Kapogiannis B, Green K. The acceptability and feasibility of an HIV pre-exposure prophylaxis (PrEP) trial with young men who have sex with men (YMSM). Journal of Acquired Immune Deficiency Syndromes (1999) [Internet]. 2013. [cited ein ein]; 62(4):[447–56 pp.]. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/241/CN-00861241/frame.html. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet. 2016;387(10013):53–60. doi: 10.1016/S0140-6736(15)00056-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine. 2015;373(23):2237–46. doi: 10.1056/NEJMoa1506273 [DOI] [PubMed] [Google Scholar]
  • 7.Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet Infectious Diseases. 2014;14(9):820–9. doi: 10.1016/S1473-3099(14)70847-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, et al. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States. Jama, Pediatr. 2017;05:05. doi: 10.1001/jamapediatrics.2017.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hosek SG, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, et al. An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. Journal of Acquired Immune Deficiency Syndromes. 2017;74(1):21–9. doi: 10.1097/QAI.0000000000001179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lal L, Audsley J, Murphy DA, Fairley CK, Stoove M, Roth N, et al. Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users. Aids. 2017;31(12):1709–14. doi: 10.1097/QAD.0000000000001519 [DOI] [PubMed] [Google Scholar]
  • 11.Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services. JAMA Internal Medicine. 2016;176(1):75–84. doi: 10.1001/jamainternmed.2015.4683 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Marcus JL, Hurley LB, Hare CB, Nguyen DP, Phengrasamy T, Silverberg MJ, et al. Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation. J Acquir Immune Defic Syndr. 2016;73(5):540–6. doi: 10.1097/QAI.0000000000001129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: An observational cohort study. The Lancet HIV. 2017. [DOI] [PubMed] [Google Scholar]
  • 14.Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, et al. No New HIV Infections with Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clinical Infectious Diseases. 2015;61(10):1601–3. doi: 10.1093/cid/civ778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Aloysius I, Savage A, Zdravkov J, Korologou-Linden R, Hill A, Smith R, et al. InterPrEP. Internet-based pre-exposure prophylaxis with generic tenofovir DF/emtricitabine in London: an analysis of outcomes in 641 patients. Journal of Virus Eradication. 2017;3(4):218–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Grinsztejn B, Hoagland B, Moreira RI, Kallas EG, Madruga JV, Goulart S, et al. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. The Lancet HIV. 2018;5(3):e136–e45. doi: 10.1016/S2352-3018(18)30008-0 [DOI] [PubMed] [Google Scholar]
  • 17.Hoagland B, Moreira RI, De Boni RB, Kallas EG, Madruga JV, Vasconcelos R, et al. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: The PrEP Brasil demonstration project. Journal of the International AIDS Society. 2017;20 (1) (no pagination)(21472). doi: 10.7448/IAS.20.1.21472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mayer KH, Agwu A, Malebranche D. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Advances in Therapy. 2020;37(5):1778–811. doi: 10.1007/s12325-020-01295-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sullivan PS, Giler RM, Mouhanna F, Pembleton ES, Guest JL, Jones J, et al. Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017. Ann Epidemiol. 2018;28(12):833–40. doi: 10.1016/j.annepidem.2018.06.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Smith DK, Van Handel M, Grey J. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol. 2018;28(12):850–7.e9. doi: 10.1016/j.annepidem.2018.05.003 [DOI] [PubMed] [Google Scholar]
  • 21.Nwokolo N, Hill A, McOwan A, Pozniak A. Rapidly declining HIV infection in MSM in central London. Lancet HIV. 2017;4(11):e482–e3. doi: 10.1016/S2352-3018(17)30181-9 [DOI] [PubMed] [Google Scholar]
  • 22.Section SFDoPH-HE. HIV Epidemiology Annual Report 2016 2017. 2017.
  • 23.Grulich A GR, Amin J, Schmidt HM, Selvey C, Holden J, et al. Rapid reduction in HIV diagnoses after targeted PrEP implementation in NSW, Australia (Conference abstract). Conf Retrovir Oppor Infect 2018. [Google Scholar]
  • 24.Institut RK. HIV/AIDS in Berlin–Eckdaten der Schätzung. Epidemiologische Kurzinformation des Robert Koch-Instituts. Stand: Ende 2019. 2020.
  • 25.Balayan T, Begovac J, Skrzat-Klapaczyńska A, Aho I, Alexiev I, Bukovinova P, et al. Where are we with pre-exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group. HIV Med. 2021;22(1):67–72. doi: 10.1111/hiv.12960 [DOI] [PubMed] [Google Scholar]
  • 26.Kirby T. PrEP finally approved on NHS in England. Lancet. 2020;395(10229):1025. doi: 10.1016/S0140-6736(20)30720-0 [DOI] [PubMed] [Google Scholar]
  • 27.Augusto GF, Hodges-Mameletzis I, Karanikolos M, Abrantes A, Martins MRO. HIV prevention and treatment in Southern Europe in the aftermath of bailout programmes. Eur J Public Health. 2020;30(5):967–73. doi: 10.1093/eurpub/ckaa062 [DOI] [PubMed] [Google Scholar]
  • 28.The Lancet HIV. For the greatest impact, end caps on PrEP access now. The Lancet HIV. 2019;6(2):e67. doi: 10.1016/S2352-3018(19)30006-2 [DOI] [PubMed] [Google Scholar]
  • 29.Hayes R, Schmidt AJ, Pharris A, Azad Y, Brown AE, Weatherburn P, et al. Estimating the ’PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019. Euro Surveill. 2019;24(41):1900598. doi: 10.2807/1560-7917.ES.2019.24.41.1900598 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Werner RN, Gaskins M, Ahrens J, Jessen H, Kutscha F, Mosdzen R, et al. Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin–A multicentre, cross-sectional survey. PLOS ONE. 2018;13(9):e0204067. doi: 10.1371/journal.pone.0204067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Moskowitz DA, Moran KO, Matson M, Alvarado-Avila A, Mustanski B. The PrEP Cascade in a National Cohort of Adolescent Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2021;86(5):536–43. doi: 10.1097/QAI.0000000000002613 [DOI] [PubMed] [Google Scholar]
  • 32.Kelley CF, Kahle E, Siegler A, Sanchez T, Del Rio C, Sullivan PS, et al. Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2015;61(10):1590–7. doi: 10.1093/cid/civ664 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, Mimiaga M, Patel R, et al. Defining the HIV pre-exposure prophylaxis care continuum. AIDS (London, England). 2017;31(5):731–4. doi: 10.1097/QAD.0000000000001385 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Parsons JT, Rendina HJ, Lassiter JM, Whitfield THF, Starks TJ, Grov C. Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2017;74(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, et al. Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco. PLOS Medicine. 2014;11(3):e1001613. doi: 10.1371/journal.pmed.1001613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Chan PA, Mena L, Patel R, Oldenburg CE, Beauchamps L, Perez-Brumer AG, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903. doi: 10.7448/IAS.19.1.20903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Newman PA, Guta A, Lacombe-Duncan A, Tepjan S. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada. J Int AIDS Soc. 2018;21(11):e25211. doi: 10.1002/jia2.25211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hughes SD, Sheon N, Andrew EVW, Cohen SE, Doblecki-Lewis S, Liu AY. Body/Selves and Beyond: Men’s Narratives of Sexual Behavior on PrEP. Med Anthropol. 2018;37(5):387–400. doi: 10.1080/01459740.2017.1416608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kutscha F, Gaskins M, Sammons M, Nast A, Werner RN. HIV Pre-Exposure Prophylaxis (PrEP) Counseling in Germany: Knowledge, Attitudes and Practice in Non-governmental and in Public HIV and STI Testing and Counseling Centers. Front Public Health. 2020;8:298. doi: 10.3389/fpubh.2020.00298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Pérez-Figueroa RE, Kapadia F, Barton SC, Eddy JA, Halkitis PN. Acceptability of PrEP Uptake Among Racially/Ethnically Diverse Young Men Who Have Sex With Men: The P18 Study. AIDS Educ Prev. 2015;27(2):112–25. doi: 10.1521/aeap.2015.27.2.112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Doblecki-Lewis S, Liu A, Feaster D, Cohen SE, Cardenas G, Bacon O, et al. Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project. J Acquir Immune Defic Syndr. 2017;74(5):531–8. doi: 10.1097/QAI.0000000000001236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature. AIDS Behav. 2017;21(5):1325–35. doi: 10.1007/s10461-016-1627-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP Implementation Through Multilevel Interventions: A Synthesis of the Literature. AIDS Behav. 2018;22(11):3681–91. doi: 10.1007/s10461-018-2184-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Siegler AJ, Bratcher A, Weiss KM. Geographic Access to Preexposure Prophylaxis Clinics Among Men Who Have Sex With Men in the United States. Am J Public Health. 2019;109(9):1216–23. doi: 10.2105/AJPH.2019.305172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216. doi: 10.1007/s10461-013-0560-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Dubov A, Galbo P Jr., Altice FL, Fraenkel L. Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study. Am J Mens Health. 2018;12(6):1843–54. doi: 10.1177/1557988318797437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Franks J, Hirsch-Moverman Y, Loquere AS Jr., Amico KR, Grant RM, Dye BJ, et al. Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study. AIDS Behav. 2018;22(4):1139–49. doi: 10.1007/s10461-017-1964-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Golub SA, Gamarel KE, Surace A. Demographic Differences in PrEP-Related Stereotypes: Implications for Implementation. AIDS Behav. 2017;21(5):1229–35. doi: 10.1007/s10461-015-1129-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Blumenthal J, Jain S, Mulvihill E, Sun S, Hanashiro M, Ellorin E, et al. Perceived Versus Calculated HIV Risk: Implications for Pre-exposure Prophylaxis Uptake in a Randomized Trial of Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2019;80(2):e23–e9. doi: 10.1097/QAI.0000000000001888 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Nydegger LA, Dickson-Gomez J, Ko Ko T. A Longitudinal, Qualitative Exploration of Perceived HIV Risk, Healthcare Experiences, and Social Support as Facilitators and Barriers to PrEP Adoption Among Black Women. AIDS Behav. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Dubov A, Altice FL, Fraenkel L. An Information-Motivation-Behavioral Skills Model of PrEP Uptake. AIDS Behav. 2018. doi: 10.1007/s10461-018-2095-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Gallagher T, Link L, Ramos M, Bottger E, Aberg J, Daskalakis D. Self-Perception of HIV Risk and Candidacy for Pre-Exposure Prophylaxis Among Men Who Have Sex with Men Testing for HIV at Commercial Sex Venues in New York City. LGBT health. 2014;1(3):218–24. doi: 10.1089/lgbt.2013.0046 [DOI] [PubMed] [Google Scholar]
  • 53.Elsesser SA, Oldenburg CE, Biello KB, Mimiaga MJ, Safren SA, Egan JE, et al. Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM). AIDS Behav. 2016;20(7):1400–7. doi: 10.1007/s10461-015-1238-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Keen P, Hammoud MA, Bourne A, Bavinton BR, Holt M, Vaccher S, et al. Use of HIV Pre-exposure Prophylaxis (PrEP) Associated With Lower HIV Anxiety Among Gay and Bisexual Men in Australia Who Are at High Risk of HIV Infection: Results From the Flux Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2020;83(2):119–25. doi: 10.1097/QAI.0000000000002232 [DOI] [PubMed] [Google Scholar]
  • 55.Irungu EM, Ngure K, Mugwanya KK, Awuor M, Dollah A, Ongolly F, et al. "Now that PrEP is reducing the risk of transmission of HIV, why then do you still insist that we use condoms?" the condom quandary among PrEP users and health care providers in Kenya. AIDS Care. 2021;33(1):92–100. doi: 10.1080/09540121.2020.1744507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Witzel TC, Nutland W, Bourne A. What are the motivations and barriers to pre-exposure prophylaxis (PrEP) use among black men who have sex with men aged 18–45 in London? Results from a qualitative study. Sex Transm Infect. 2019;95(4):262–6. doi: 10.1136/sextrans-2018-053773 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Collins SP, McMahan VM, Stekler JD. The Impact of HIV Pre-exposure Prophylaxis (PrEP) Use on the Sexual Health of Men Who Have Sex with Men: A Qualitative Study in Seattle, WA. International Journal of Sexual Health. 2017;29(1):55–68. [Google Scholar]
  • 58.Gamarel KE, Golub SA. Intimacy motivations and pre-exposure prophylaxis (PrEP) adoption intentions among HIV-negative men who have sex with men (MSM) in romantic relationships. Annals of behavioral medicine: a publication of the Society of Behavioral Medicine. 2015;49(2):177–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Eaton LA, Kalichman SC, Price D, Finneran S, Allen A, Maksut J. Stigma and Conspiracy Beliefs Related to Pre-exposure Prophylaxis (PrEP) and Interest in Using PrEP Among Black and White Men and Transgender Women Who Have Sex with Men. AIDS Behav. 2017;21(5):1236–46. doi: 10.1007/s10461-017-1690-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Calabrese SK, Underhill K. How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores". Am J Public Health. 2015;105(10):1960–4. doi: 10.2105/AJPH.2015.302816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Lacombe-Duncan A, Guta A, Newman PA. Pre-Exposure Prophylaxis (PrEP) Implementation for Gay, Bisexual, and Other Men Who Have Sex with Men: Implications for Social Work Practice. Health Soc Work. 2021;46(1):22–32. doi: 10.1093/hsw/hlaa038 [DOI] [PubMed] [Google Scholar]
  • 62.Alwin DF. How Good is Survey Measurement? Assessing the Reliability and Validity of Survey Measures. In: Marsden PVW, James D., editor. The SAGE Handbook of Survey Methodology. United Kingdom: Emerald Group Publishing Ltd.; 2010. [Google Scholar]
  • 63.Alwin DF. Margins of error: A study of reliability in survey measurement. Margins of error: A study of reliability in survey measurement. Hoboken, NJ, US: Wiley-Interscience. p. xvi, 389-xvi,. [Google Scholar]
  • 64.Sepodes B, Rocha J, Batista J, Figueira M-E, Dráfi F, Torre C. Implementation and Access to Pre-exposure Prophylaxis for Human Immunodeficiency Virus by Men Who Have Sex With Men in Europe. Frontiers in Medicine. 2021;8(1339). doi: 10.3389/fmed.2021.722247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.(AWMF) AdWMF. S2k Deutsche-Österreichische Leitlinien zur HIV-Präexpositionsprophylaxe (AWMF-Register-Nr.: 055–008) 2018 [Available from: https://www.awmf.org/uploads/tx_szleitlinien/055-008l_S2k_HIV-Praeexpositionsprophylaxe_2019-01_01.pdf.
  • 66.Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Medical Research Methodology. 2013;13(1):117. doi: 10.1186/1471-2288-13-117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Nowell LS, Norris JM, White DE, Moules NJ. Thematic Analysis: Striving to Meet the Trustworthiness Criteria. International Journal of Qualitative Methods. 2017;16(1):1609406917733847. [Google Scholar]
  • 68.Frankis J, Young I, Flowers P, McDaid L. Who Will Use Pre-Exposure Prophylaxis (PrEP) and Why?: Understanding PrEP Awareness and Acceptability amongst Men Who Have Sex with Men in the UK—A Mixed Methods Study. PLoS One. 2016;11(4):e0151385. doi: 10.1371/journal.pone.0151385 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Eakle R, Bourne A, Jarrett C, Stadler J, Larson H. Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography. BMC Public Health. 2017;17(1):968. doi: 10.1186/s12889-017-4959-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Shrestha R, Altice FL, Huedo-Medina TB, Karki P, Copenhaver M. Willingness to Use Pre-Exposure Prophylaxis (PrEP): An Empirical Test of the Information-Motivation-Behavioral Skills (IMB) Model among High-Risk Drug Users in Treatment. AIDS Behav. 2017;21(5):1299–308. doi: 10.1007/s10461-016-1650-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Shrestha R, Altice FL, Karki P, Copenhaver MM. Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study. AIDS Behav. 2018. doi: 10.1007/s10461-018-2099-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Saldana J. The Coding Manual for Qualitative Researchers: SAGE Publications; 2015. [Google Scholar]
  • 73.Hoff CC, Chakravarty D, Bircher AE, Campbell CK, Grisham K, Neilands TB, et al. Attitudes Towards PrEP and Anticipated Condom Use Among Concordant HIV-Negative and HIV-Discordant Male Couples. AIDS patient care and STDs. 2015;29(7):408–17. doi: 10.1089/apc.2014.0315 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Nimmons D, Folkman S. Other-Sensitive Motivation for Safer Sex Among Gay Men: Expanding Paradigms for HIV Prevention. AIDS Behav [Internet]. 1999; 3(4):[313–24 pp.]. doi: 10.1023/a:1025429216459 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Blackstock OJ, Moore BA, Berkenblit GV, Calabrese SK, Cunningham CO, Fiellin DA, et al. A Cross-Sectional Online Survey of HIV Pre-Exposure Prophylaxis Adoption Among Primary Care Physicians. J Gen Intern Med. 2017;32(1):62–70. doi: 10.1007/s11606-016-3903-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Golub SA. PrEP Stigma: Implicit and Explicit Drivers of Disparity. Curr HIV/AIDS Rep. 2018;15(2):190–7. doi: 10.1007/s11904-018-0385-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Karris MY, Beekmann SE, Mehta SR, Anderson CM, Polgreen PM. Are We Prepped for Preexposure Prophylaxis (PrEP)? Provider Opinions on the Real-World Use of PrEP in the United States and Canada. Clinical Infectious Diseases. 2013;58(5):704–12. doi: 10.1093/cid/cit796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Alaei K, Paynter CA, Juan SC, Alaei A. Using preexposure prophylaxis, losing condoms? Preexposure prophylaxis promotion may undermine safe sex. Aids. 2016;30(18):2753–6. doi: 10.1097/QAD.0000000000001262 [DOI] [PubMed] [Google Scholar]
  • 79.EMA. Reflection paper on the non-clinical and clinical development for oral and topical HIV pre-exposure prophylaxis (PrEP) London; 2012.
  • 80.Gafos M, Horne R, Nutland W, Bell G, Rae C, Wayal S, et al. The Context of Sexual Risk Behaviour Among Men Who Have Sex with Men Seeking PrEP, and the Impact of PrEP on Sexual Behaviour. AIDS and Behavior. 2019;23(7):1708–20. doi: 10.1007/s10461-018-2300-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Batejan KL, Jarvi SM, Swenson LP. Sexual orientation and non-suicidal self-injury: a meta-analytic review. Arch Suicide Res. 2015;19(2):131–50. doi: 10.1080/13811118.2014.957450 [DOI] [PubMed] [Google Scholar]
  • 82.King M, Semlyen J, Tai SS, Killaspy H, Osborn D, Popelyuk D, et al. A systematic review of mental disorder, suicide, and deliberate self harm in lesbian, gay and bisexual people. BMC Psychiatry. 2008;8:70. doi: 10.1186/1471-244X-8-70 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Marshal MP, Dietz LJ, Friedman MS, Stall R, Smith HA, McGinley J, et al. Suicidality and depression disparities between sexual minority and heterosexual youth: a meta-analytic review. J Adolesc Health. 2011;49(2):115–23. doi: 10.1016/j.jadohealth.2011.02.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Freeborn K, Portillo CJ. Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review. J Clin Nurs. 2018;27(17–18):3254–65. doi: 10.1111/jocn.13990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, et al. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection. JAMA. 2019;321(14):1380–90. doi: 10.1001/jama.2019.2947 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Nguyen V-K, Greenwald ZR, Trottier H, Cadieux M, Goyette A, Beauchemin M, et al. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS (London, England). 2018;32:523–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Hillis A, Germain J, Hope V, McVeigh J, Van Hout MC. Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming. AIDS Behav. 2020;24(11):3056–70. doi: 10.1007/s10461-020-02855-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.O’Dell BL, Rosser BR, Miner MH, Jacoby SM. HIV prevention altruism and sexual risk behavior in HIV-positive men who have sex with men. AIDS Behav. 2008;12(5):713–20. doi: 10.1007/s10461-007-9321-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Kappes A, Nussberger AM, Faber NS, Kahane G, Savulescu J, Crockett MJ. Uncertainty about the impact of social decisions increases prosocial behaviour. Nat Hum Behav. 2018;2(8):573–80. doi: 10.1038/s41562-018-0372-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Klassen BJ, Fulcher K, Chown SA, Armstrong HL, Hogg RS, Moore DM, et al. “Condoms are … like public transit. It’s something you want everyone else to take”: Perceptions and use of condoms among HIV negative gay men in Vancouver, Canada in the era of biomedical and seroadaptive prevention. BMC Public Health. 2019;19(1):120. doi: 10.1186/s12889-019-6452-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Jonas KJ, Hawk ST, Vastenburg D, de Groot P. "Bareback" pornography consumption and safe-sex intentions of men having sex with men. Arch Sex Behav. 2014;43(4):745–53. doi: 10.1007/s10508-014-0294-2 [DOI] [PubMed] [Google Scholar]
  • 92.Phillips DL, Clancy KJ. Some Effects of "Social Desirability" in Survey Studies. American Journal of Sociology. 1972;77(5):921–40. [Google Scholar]
  • 93.Paulhus DL. Measurement and control of response bias. Measures of personality and social psychological attitudes. San Diego, CA, US: Academic Press; 1991. p. 17–59. [Google Scholar]
  • 94.Mensch BS, Kandel DB. Underreporting of substance use in a national longitudinal youth cohort: Individual and interviewer effects. Public Opinion Quarterly. 1988;52(1):100–24. [Google Scholar]
  • 95.Are studies of dark side variables confounded by socially desirable responding? The case of materialism [press release]. US: Univ of Chicago Press; 1996. [Google Scholar]
  • 96.Catania JA, Gibson DR, Chitwood DD, Coates TJ. Methodological problems in AIDS behavioral research: influences on measurement error and participation bias in studies of sexual behavior. Psychol Bull. 1990;108(3):339–62. doi: 10.1037/0033-2909.108.3.339 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Peter A Newman

22 Jul 2021

PONE-D-21-17716

Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A mixed-methods analysis of data from a multicentre survey

PLOS ONE

Dear Dr. Gaskins,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Both reviewers found the paper interesting and valuable, but they raised a number of important issues that need to be addressed. These include clarifying the study background and reframing the rationale; referencing and addressing a number of relevant studies that are omitted (in Intro and Discussion); more fully describing the methods and data analysi; and providing context on PrEP availability in Germany and the broader EU context for international readers.

Please submit your revised manuscript by Sep 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Peter A Newman, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed the survey or questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. If the questionnaire is published, please provide a citation to the (1) questionnaire and/or (2) original publication associated with the questionnaire.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to review “Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A mixed-methods analysis of data from a multi-centre survey”. The authors conducted a thorough analysis of both quantitative and qualitative data from a cross-sectional survey conducted with a relatively large sample of MSM with complete data on the qualitative component (n=228). The manuscript contributes to the broader literature about the importance of understanding social and structural factors in PrEP uptake. The authors’ conclusion that health professionals seeking to increase PrEP uptake need take a holistic approach that emphasizes multiple motivations is well-founded in their data. My enthusiasm for this manuscript is tempered by three major concerns. Specifically, the manuscript is in need of: 1) a more thorough literature review that draws on existing research about motivations for PrEP use; 2) clarification of the mixed-methods methodology; and 3) re-structuring of the methods/results. In addition to providing more details regarding these concerns, I offer some additional feedback by manuscript section below for the authors’ consideration.

Abstract

I’m not completely clear based on the results presented in the abstract how recognition of multiple and varied motivations may reassure practitioners concerned about condom use in relation to PrEP, particularly when the authors note that almost 1/5 intended not to use condoms. I would consider removing that line, as it requires too much context to be flushed out in an abstract in a nuanced way, but is explored in more depth in the discussion section of the manuscript.

I’m unclear exactly what the authors mean by ‘categories’ in the sentence “…responses overall were heterogeneous, even within categories”; additional clarification would be most helpful.

I appreciate the last line of the conclusion as a clear message for practitioners that is well-founded in the data.

Introduction

The authors strong opening paragraphs which detail the background of PrEP approval, the importance of PrEP to reducing HIV disparities particularly among MSM, and context of PrEP uptake in Berlin, Germany. In paragraph 2, it would be helpful for the authors to hypothesize or provide data pertaining to why those who were likely to use PrEP were not able to access it. I would also be interested to know a bit more about why policy makers in many countries are debating integration of PrEP into publicly-funded systems, but recognize that this may be beyond the scope of the paper.

In between the lines starting “As of late 2019…” and “This is unfortunate…” it would be helpful to add one line and associated references that refers to the disproportionate prevalence of HIV among MSM in the US context (see: https://www.cdc.gov/hiv/group/msm/index.html).

In terms of flow, I would consider switching the order of paragraphs 3 on the PrEP continuum of care and paragraph 4 on barriers to PrEP uptake.

I appreciate the authors’ attentiveness to social and structural barriers to PrEP uptake and considerations of a PrEP continuum of care. To that end, there is some literature that should be integrated into the PrEP continuum of care paragraph as well as used to contextualize the discussion. Please see:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253066/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315535/

https://journals.lww.com/jaids/Abstract/2021/04150/The_PrEP_Cascade_in_a_National_Cohort_of.4.aspx?context=LatestArticles

While the latter two articles follow more biomedically-oriented conceptualizations of a PrEP cascade, the first article (Newman et al., 2018) details social and structural considerations of PrEP uptake across a PrEP continuum of care, some of which overlaps with the findings of this manuscript. Moreover, given the topic of the paper is on motivations of PrEP use, I believe that the sentence “However, our knowledge about explicit motivations that influence decisions to initiate PrEP is less well developed and stems mostly from small qualitative studies involving focus groups or interviews [38-42]” warrants it’s own paragraph and more details. There is also additional research on motivations for PrEP use, some of which corroborates the findings of the researchers, that could be integrated into the introduction and the discussion, for example:

https://sti.bmj.com/content/95/4/262.abstract

https://academic.oup.com/abm/article/49/2/177/4561523?login=true

Then, it may be helpful to add one additional statement explicitly summarizing gaps in the evidence base.

Minor notes: line 78 at first mention of United States include US in brackets, as you use US throughout after that; also, MSM should be spelled out at first mention.

Materials and Methods

I appreciated the thorough overview of recruitment, and in particular the in-depth description of the non-municipal counselling and testing centers and HIV specialist services.

Was there a rationale for randomly selecting 30 out of 228 responses to create the coding framework? For example, did the authors reach some level of saturation (no new category generation) by open-text response 30? Upon coding the remaining free-text responses, were there any motivations that did not fit within the originally-developed framework? If so, how did the authors resolve this?

In terms of structure, I believe it would be clearer if the sub-heading ‘Literature search’ was removed and the literature search paragraph integrated into the analysis section before the line “These two classifications systems…”. Moreover, the operationalization of the PrEP care continuum is related to the quantitative analysis and could be absolved into that section before the line beginning with “For any post-hoc pairwise comparisons…”

Table 1: I appreciate the authors’ integration of references. Some of the suggested references above may also be able to be integrated into the table so that there are references for most of the sub-categories (E.g., Newman et al. (2018) could be used to reference ‘expectations of more pleasureful sex or increased intimacy and closeness (when not using a condom)’, ‘ expectations of worry-free sex’, ‘desire to increase quality of life or sexual/personal freedom’, ‘reducing anxiety, fear, or worries of being infected with HIV’, and ‘autonomy and self-empowerment in the protection against HIV’, among other sub-categories.

One aspect I wondered about in the Abstract, and now here, is the potential overlap between ‘worry-free sex’ and ‘reducing anxiety, fear, or worries of being infected with HIV’ – can the authors expand more on how they are conceptualizing the difference between these sub-categories throughout the manuscript.

For clarity, I suggest using the sub-headings ‘Qualitative data analysis’ (for section that is now called Data analysis) and then ‘Quantitative data analysis’ (for the section that is now called Sample size and statistical methods).

The way that the study is currently depicted is as a multi-method as opposed to a mixed-methods study. Mixed methods is an in-depth methodology that goes beyond the rigorous collection and analysis of both quantitative and qualitative data to include the integration of the two forms of data using a pre-specified mixed methods typology (See: Creswell & Plano-Clark, 2017), thus, more details about the mixed-methods methodology should be included. As the key to mixed-methods is integration of quantitative and qualitative data, if mixed-methods is maintained as the methodology, another section should be added titled ‘Mixed methods analysis’ that details how quantitative and qualitative data were compared/contrasted (See: Fetters, Curry, & Creswell, 2013). Alternately, the authors may opt to refer to their study as a multi-method study

Minor: Please spell in full at first use of LGBTI+.

Results

The first paragraph of the results could be integrated within the methods section ‘Sampling methods, participants, and settings’, up until the last line; the last line could be included in the section ‘Demographic data, sexual behavior, and HIV risk of analysis sample’.

Table 2 – rows with 0 responses (e.g., primary education, small town/rural area in Germany) could be omitted.

The lines “There was a high degree of agreement between the coding results…” should be integrated within the qualitative data analysis sub-section. The subsection coding of responses could be more appropriately titled Motivations of Participants (or something similar). I don’t think the line “there were no disagreements between the reviewers in this regard” is needed – if maintained, it should also be moved to the analysis.

I may have missed it, but I’m not clear how the authors classified a motivation as a main motivation – does this just mean that the participant wrote it down as a motivation, or did the authors denote some order as to what was main when participants indicated more than one motivation? Please clarify.

Discussion

I am wondering if the authors have more context about provider concern about condom use as leading to hesitancy about PrEP – is this an issue in the EU context that has prevented widespread adoption of PrEP into public insurance plans? Additional references would be helpful.

The authors may also consider a broader discussion of literature pertaining to PrEP counselling from a holistic lens, as they are describing, see:

https://academic.oup.com/hsw/article-abstract/46/1/22/6151208

https://link.springer.com/article/10.1007/s10461-020-02855-9

https://www.tandfonline.com/doi/abs/10.1080/09540121.2020.1744507

Excellent overview of the limitations of the study.

Reviewer #2: This paper reviews the motivations for PrEP use among a sample of MSM living in Berlin. It is methodologically sound and well-written with some thought-provoking conclusions, particularly with respect to the mental health circumstances of MSM and how these may be alleviated, for some, by the use PrEP. There are, however, a few issues that I think need to be addressed before it is ready for publication.

1. Recognising and reflecting previous research. The emergence of PrEP has seen a significant number of papers published that examine: the acceptability of PrEP; motivations for PrEP use; factors that may influence PrEP uptake and continued use; how PrEP is integrated into sexual lives; how PrEP reforms how MSM think about HIV risk, etc. As the key rationale for the study, the authors states that most prior research has been focus group or interview based and, therefore, larger scale data is required. I’m not sure this accurately reflects the nature of the literature on this topic (where there are a number of quantitative or survey-based studies) nor does being ‘bigger’ necessarily constitute a clear rationale for this study. I would encourage the authors to acknowledge the large amount of quantitative literature on this topic (look, for example, at work by Bavinton, Prestage and Holt, among others) and consider recasting the principle rationale for the study to identify what is unique.

2. Acceptable in theory and in practice. Partially linked to the point above, prior to the widespread rollout of PrEP there were a large number of studies looking at the theoretical acceptability of PrEP (see review by Ingrid Young). What I found myself wondering was how the findings of your study – when people CAN actually access and use PrEP differ from/relate to the motivations MSM provided when talking about PrEP in the abstract. Can you reflect some of this literature in your discussion?

3. Coding frame. Can you provide a clear rationale as to why you created a coding frame from a review of the literature and applied it to your data, rather than working with the data in an inductive manner? I also think it would be much easier to follow if you describe the literature review process, and its purpose, prior to presenting the coding frame.

4. As a minor point, can you include a short summary as to the status of PrEP availability in Germany a the time of data collection? Where could it be obtained? How much did it cost? What prescribing criteria has to be met? Such information would aid interpretation from an international audience.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Nov 18;16(11):e0260168. doi: 10.1371/journal.pone.0260168.r002

Author response to Decision Letter 0


8 Sep 2021

Dear Professor Newman,

Dear members of the Editorial Board,

Dear Reviewers,

We would like to thank the academic editor and each of the reviewers for their careful review of our manuscript and their thorough and very helpful suggestions for improving it. We feel that the manuscript has benefitted greatly as a result. Please find our replies to each of their points in the rebuttal letter we have uploaded, including details on how we have implemented their suggestions. Please note that all line numbers in the rebuttal letter refer to the file ‘Revised Manuscript with Track Changes’. (If the reviewers prefer that the line numbers refer to the clean file without track changes, we would be happy to send a revised point-by-point reply letter with these instead.)

Yours sincerely,

Matthew Gaskins

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Peter A Newman

4 Nov 2021

Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A multi-methods analysis of data from a multicentre survey

PONE-D-21-17716R1

Dear Dr. Gaskins,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Peter A Newman, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the opportunity to re-review the manuscript now titled “Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A multi-methods analysis of data from a multi-centre study”. The authors have addressed my comments to a high degree of quality. I agree with the authors' assessment that the expanded literature review leads into a clearer rationale for the study, both from a methodological and study site (geographic) perspective. The methodology is now clearer as described as a multi-methods study. The added description of qualitative analyses and restructuring of the methods (particularly moving the section previously entitled literature review) has also strengthened the clarity of the manuscript. I just have one minor comment: Where the authors quote Young & McDaid in the introduction a page number is needed.

Reviewer #2: I congratulate the authors on a really comprehensive revision of their manuscript. The integration of existing research, coupled with a reflection on how PrEP is perceived in practice (rather than just in theory) has helped to ensure a much more convincing rationale for the paper. The methodology is also much more clear now that the inductive-deductive process of data coding has been explained in more detail. It makes a useful addition to the literature on this topic.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Adam Bourne

Acceptance letter

Peter A Newman

9 Nov 2021

PONE-D-21-17716R1

Factors that motivate men who have sex with men in Berlin, Germany, to use or consider using HIV pre-exposure prophylaxis – A multi-methods analysis of data from a multicentre survey

Dear Dr. Gaskins:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Peter A Newman

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Demographic data and sexual risk behaviour of participants in analysis sample and participants who were neutral about or potentially interested in taking PrEP but who did not answer the question about their main motivation.

    (DOCX)

    S1 Dataset. Minimal underlying data set and codebook.

    Age of respondents has been removed to ensure patient anonymity.

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES